COVID-19
Why the suspended AstraZeneca trial is good news for vaccine safety
Published Sept 10, 2020Emergency medicine specialist Lauren Sauer tells 'Bloomberg' that although the setback delays coronavirus vaccine development, the final product will be safer for the public
/ Bloomberg
